Cargando…

Can Pulmonary Arterial Compliance Be a Prognostic Marker for Pulmonary Hypertension?

Detalles Bibliográficos
Autores principales:	Wu, Yanjuan, Su, Xiaofen, Wang, Jingcun, Zhang, Haojie, Zeng, Xiangxia, Zhang, Sun, Zhang, Nuofu, Wu, Kang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563186/ https://www.ncbi.nlm.nih.gov/pubmed/37562031 http://dx.doi.org/10.1164/rccm.202306-1076LE

Ejemplares similares

Pulmonary Hypertension: A Predictor of Lung Cancer Prognosis?
por: Zheng, Zhenzhen, et al.
Publicado: (2021)

The isobaric pulmonary arterial compliance in pulmonary hypertension
por: Chemla, Denis, et al.
Publicado: (2021)

Prognostic Value of Exercise as Compared to Resting Pulmonary Hypertension in Patients with Normal or Mildly Elevated Pulmonary Arterial Pressure
por: Douschan, Philipp, et al.
Publicado: (2022)

Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension
por: Weatherald, Jason, et al.
Publicado: (2023)

Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
por: Weatherald, Jason, et al.
Publicado: (2021)

Pulmonary Vasculature: A Target for COVID-19
por: Chen, Lingdan, et al.
Publicado: (2021)

Incidence and outcomes of COVID-19 in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Data from the Hellenic pulmOnary hyPertension rEgistry (HOPE)
por: Farmakis, Ioannis T., et al.
Publicado: (2022)

Relationship between compliance and pulmonary vascular resistance in pulmonary arterial hypertension
por: Guigui, Sarah, et al.
Publicado: (2020)

Oral treprostinil improves pulmonary vascular compliance in pulmonary arterial hypertension
por: Khan, Akram, et al.
Publicado: (2022)

A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension
por: Mohamed, Nura A., et al.
Publicado: (2016)

Improvement of pulmonary arterial compliance by pulmonary vasodilator in pulmonary hypertension from combined pulmonary fibrosis and emphysema
por: Kusaka, Kei, et al.
Publicado: (2019)

The prognostic value of pulmonary artery compliance in cardiogenic shock
por: Zorzi, Maria F., et al.
Publicado: (2019)

Reply to Weatherald et al.: Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
por: Badagliacca, Roberto, et al.
Publicado: (2021)

BET Bromodomain Inhibitors and Pulmonary Arterial Hypertension: Take Care of the Heart
por: Piquereau, Jérôme, et al.
Publicado: (2019)

More Insights into the Association between RVX-208 and Pulmonary Arterial Hypertension
por: Ning, Dong, et al.
Publicado: (2020)

CBLN2 rs2217560 was Associated with Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus
por: Huang, Can, et al.
Publicado: (2018)

Bilirubin as a prognostic marker in patients with pulmonary arterial hypertension
por: Takeda, Yasuko, et al.
Publicado: (2010)

Quality of life as a prognostic marker in pulmonary arterial hypertension
por: Fernandes, Caio JCS, et al.
Publicado: (2014)

Establishment and Application Evaluation of an Improved Obstructive Sleep Apnea Screening Questionnaire for Chinese Community: The CNCQ-OSA
por: Wang, Donghao, et al.
Publicado: (2023)

Pulmonary arterial compliance and exercise capacity after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension
por: Sermet, Romain, et al.
Publicado: (2023)

Prognostic Value of Oxidative Stress Markers in Patients with Pulmonary Arterial or Chronic Thromboembolic Pulmonary Hypertension
por: Smukowska-Gorynia, Anna, et al.
Publicado: (2019)

EpiHope for the Treatment of Pulmonary Arterial Hypertension: Selective versus Nonselective BET Inhibition
por: Pullamsetti, Soni Savai, et al.
Publicado: (2019)

Pulmonary artery hypertension in mitral stenosis: Role of right ventricular stroke volume, atrio-ventricular compliance, and pulmonary venous compliance
por: Neema, Praveen Kumar, et al.
Publicado: (2012)

Learning curve and analysis of curative effects after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
por: Hong, Cheng, et al.
Publicado: (2023)

Cognitive Dysfunction in Patients with Pulmonary Hypertension
por: Yuan, Ping, et al.
Publicado: (2022)

Effect of COVID-19 in Pulmonary Hypertension
por: Jha, Ajay Kumar
Publicado: (2022)

Obstructive Sleep Apnea with High Pulse Wave Amplitude Drops Index: A Specific Phenotype for Cardiovascular Benefit from Continuous Positive Airway Pressure?
por: Chen, Yating, et al.
Publicado: (2023)

Positron Emission Tomography: A Novel Approach to Detect Pulmonary Artery Hypertension at the Early Stage?
por: Tang, Ruidi, et al.
Publicado: (2020)

Percutaneous pulmonary artery biodegradable stent: a new armament to fight pulmonary artery stenosis?
por: Zou, Hai, et al.
Publicado: (2020)

Net atrioventricular compliance can predict persistent pulmonary artery hypertension after percutaneous mitral balloon commissurotomy
por: Al-Daydamony, Mohammad M., et al.
Publicado: (2017)

Can N3 Period Duration Serve as a Predictor of Cognitive Dysfunction?
por: Zheng, Zhenzhen, et al.
Publicado: (2021)

Association Between Smoking Behavior and Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis
por: Zeng, Xiangxia, et al.
Publicado: (2022)

Emphysema Is—at the Most—Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension
por: Bogaard, Harm J., et al.
Publicado: (2019)

Reply to Ning et al.: More Insights into the Association between RVX-208 and Pulmonary Arterial Hypertension
por: Provencher, Steeve, et al.
Publicado: (2020)

Outpatient Inhaled Nitric Oxide in a Patient with Vasoreactive Idiopathic Pulmonary Arterial Hypertension and COVID-19 Infection
por: Zamanian, Roham T., et al.
Publicado: (2020)

Pulmonary Hypertension in Glycogen Storage Disease Type II
por: Li, Hui-Ping, et al.
Publicado: (2018)

Prognostic Power of Pulmonary Arterial Compliance Is Boosted by a Hemodynamic Unloading Test With Glyceryl Trinitrate in Heart Failure Patients With Post-capillary Pulmonary Hypertension
por: Rieth, Andreas J., et al.
Publicado: (2022)

Pulmonary arterial stent for pulmonary trunk stenosis after size-mismatched lung transplantation
por: Xiao, Fei, et al.
Publicado: (2019)

Targeting Pulmonary Hypertension Caused by Pulmonary Fibrosis: A Promising Natural Killer T Cell–based Therapy
por: Wang, Zi-Hao, et al.
Publicado: (2023)

Co-profiling reveals distinct patterns of genomic chromatin accessibility and gene expression in pulmonary hypertension caused by chronic hypoxia
por: Yu, Dongdong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0po7n2p9htir39oeoat8v8j3ud